These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32561369)

  • 21. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.
    Barbieri JS; Choi JK; James WD; Margolis DJ
    J Am Acad Dermatol; 2019 Sep; 81(3):848-851. PubMed ID: 30905798
    [No Abstract]   [Full Text] [Related]  

  • 22. What do we know about prescribing spironolactone for acne?
    Santer M; Layton A
    BMJ; 2023 May; 381():1114. PubMed ID: 37197774
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians.
    Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Watanabe-Ono A; Suga H; Inoue K; Gonda K; Yoshimura K
    Aesthetic Plast Surg; 2006; 30(6):689-94. PubMed ID: 17077951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraceptive use in acne.
    Lam C; Zaenglein AL
    Clin Dermatol; 2014; 32(4):502-15. PubMed ID: 25017461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty.
    Zhang M; Silverberg JI; Kaffenberger BH
    J Am Acad Dermatol; 2017 Sep; 77(3):448-455.e2. PubMed ID: 28651825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety of spironolactone in acne: results of an 8-year followup study.
    Shaw JC; White LE
    J Cutan Med Surg; 2002; 6(6):541-5. PubMed ID: 12219252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergic contact dermatitis from spironolactone.
    Corazza M; Strumìa R; Lombardi AR; Virgili A
    Contact Dermatitis; 1996 Dec; 35(6):365-6. PubMed ID: 9118635
    [No Abstract]   [Full Text] [Related]  

  • 28. The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study.
    Park JH; Bienenfeld A; Orlow SJ; Nagler AR
    Am J Clin Dermatol; 2018 Jun; 19(3):449-455. PubMed ID: 29556985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
    Plovanich M; Weng QY; Mostaghimi A
    JAMA Dermatol; 2015 Sep; 151(9):941-4. PubMed ID: 25796182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of dermatologists and family physicians in terms of prescribing antibiotics for the treatment of acne vulgaris.
    Aslan Kayıran M; Karadağ AS; Mutlu HH; Goldust M; Sarıcaoğlu H
    Dermatol Ther; 2020 Nov; 33(6):e13973. PubMed ID: 32621767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming acne care by pediatricians: An interventional cohort study.
    Borok J; Udkoff J; Vaida F; Murphy J; Torriani F; Waldman A; Ahluwalia J; Eichenfield LF
    J Am Acad Dermatol; 2018 Nov; 79(5):966-968. PubMed ID: 29753064
    [No Abstract]   [Full Text] [Related]  

  • 32. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in acne therapy prescribing patterns between dermatologists and pediatricians: A population-based study.
    Jones ME; Pourali SP; Kohn AH; Gutierrez Y; Rajkumar JR; Armstrong AW
    Pediatr Dermatol; 2021 Sep; 38(5):1150-1156. PubMed ID: 34514637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral antibiotics in acne: a retrospective single-centre analysis of current prescribing in primary care and its alignment with the national antibiotic quality premium.
    Whitehouse H; Solman L; Eady EA; Layton AM
    Br J Dermatol; 2019 Dec; 181(6):1341-1342. PubMed ID: 31301232
    [No Abstract]   [Full Text] [Related]  

  • 35. Physicians underutilize topical retinoids in the management of acne vulgaris: analysis of U.S. National Practice Data.
    Balkrishnan R; Fleischer AB; Paruthi S; Feldman SR
    J Dermatolog Treat; 2003 Sep; 14(3):172-6. PubMed ID: 14522620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Antibiotics for Acne.
    Patel DJ; Bhatia N
    Am J Clin Dermatol; 2021 Mar; 22(2):193-204. PubMed ID: 32918267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minocycline for acne. Doctors should not change the way they prescribe for acne.
    Cunliffe WJ
    BMJ; 1996 Apr; 312(7038):1101. PubMed ID: 8616440
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term use of spironolactone for acne in women: A case series of 403 patients.
    Garg V; Choi JK; James WD; Barbieri JS
    J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.